ArticleJournal of medicine and life2023

Targeting VEGF using Bevacizumab attenuates sepsis-induced liver injury in a mouse model of cecal ligation and puncture.

Aula Zaini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.